These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31661724)

  • 21. The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.
    Ogino Y; Wakui N; Nagai H; Igarashi Y
    JGH Open; 2021 Aug; 5(8):947-952. PubMed ID: 34386604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF).
    Kobyliak N; Dynnyk O; Savytska M; Solodovnyk O; Zakomornyi O; Оmеlchenko O; Kushnir A; Titorenko R
    Heliyon; 2023 Oct; 9(10):e20642. PubMed ID: 37818006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease.
    Kaposi PN; Zsombor Z; Rónaszéki AD; Budai BK; Csongrády B; Stollmayer R; Kalina I; Győri G; Bérczi V; Werling K; Maurovich-Horvat P; Folhoffer A; Hagymási K
    Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children With Non-Alcoholic Fatty Liver Disease.
    Yodoshi T; Orkin S; Trout AT; Arce-Clachar AC; Bramlage K; Liu C; Fei L; Dillman JR; Xanthakos SA; Mouzaki M
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):495-502. PubMed ID: 34908012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis.
    Zhao Y; Jia M; Zhang C; Feng X; Chen J; Li Q; Zhang Y; Xu W; Dong Y; Jiang Y; Liu Y; Huang P
    Sci Rep; 2022 Feb; 12(1):2876. PubMed ID: 35190618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
    Seo DM; Lee SM; Park JW; Kim MJ; Ha HI; Park SY; Lee K
    Ultrasonography; 2023 Apr; 42(2):227-237. PubMed ID: 36935602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different Ultrasound Shear Wave Elastography Techniques as Novel Imaging-Based Approaches for Quantitative Evaluation of Hepatic Steatosis-Preliminary Findings.
    Platz Batista da Silva N; Scharf G; Lürken L; Verloh N; Schleder S; Stroszczynski C; Jung EM; Haimerl M
    Tomography; 2023 Mar; 9(2):681-692. PubMed ID: 36961013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
    Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
    BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
    Kuroda H; Oguri T; Kamiyama N; Toyoda H; Yasuda S; Imajo K; Suzuki Y; Sugimoto K; Akita T; Tanaka J; Yasui Y; Kurosaki M; Izumi N; Nakajima A; Fujiwara Y; Abe T; Kakisaka K; Matsumoto T; Kumada T
    Radiology; 2023 Oct; 309(1):e230341. PubMed ID: 37787670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
    Fujiwara Y; Kuroda H; Abe T; Ishida K; Oguri T; Noguchi S; Sugai T; Kamiyama N; Takikawa Y
    Ultrasound Med Biol; 2018 Nov; 44(11):2223-2232. PubMed ID: 30077415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease.
    Grąt K; Grąt M; Rowiński O
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32839409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom.
    Labyed Y; Milkowski A
    J Ultrasound Med; 2020 Dec; 39(12):2427-2438. PubMed ID: 32525261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
    Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
    J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
    Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging-derived proton density fat fraction.
    Ogawa S; Kumada T; Gotoh T; Niwa F; Toyoda H; Tanaka J; Shimizu M
    Hepatol Res; 2024 Jul; 54(7):638-654. PubMed ID: 38294946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis.
    Rónaszéki AD; Budai BK; Csongrády B; Stollmayer R; Hagymási K; Werling K; Fodor T; Folhoffer A; Kalina I; Győri G; Maurovich-Horvat P; Kaposi PN
    Medicine (Baltimore); 2022 Aug; 101(33):e29708. PubMed ID: 35984128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
    Yoo J; Joo I; Jeon SK; Park J; Yoon SH
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38393403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.